Hi Guest
medicines onlineMedicines1mglabsLab Testsonline consultationeConsultNEWHealth product categoriesHealth productsNEWHealth Care ArticlesArticlesDoctorsDoctorsNEW
My Orders
Need Help?NEW
Login
Signup
online pharmacy
New Delhi
Browse our Health Products

Diprowize OD 750 Tablet PR

generic_icon
Rs.186for 1 strip(s) (10 Tablet pr each)
1
దురదృష్టవశాత్తు, మా వద్ద ఇంకా ఎక్కువ ఐటమ్‌లు స్టాకులో లేవు.
కార్ట్‌కు జోడించండి
INSTALL APP
Get 20% Off On Diprowize Tablet PR OD 750
INSTALL APP
దోషాన్ని నివేదించడం

Diprowize 750mg Tablet PR కొరకు కూర్పు

Divalproex(750mg)

Diprowize Tablet PR కొరకు ఆహారం సంపర్కం

Diprowize Tablet PR కొరకు ఆల్కహాల్ సంపర్కం

Diprowize Tablet PR కొరకు గర్భధారణ సంపర్కం

Diprowize Tablet PR కొరకు చనుబాలివ్వడం సంపర్కం

ఆహారం
ఆల్కహాల్
గర్భధారణ
చనుబాలివ్వడం
Diprowize OD 750 Tablet PR may be taken with or without food, but it is better to take it at a fixed time.
None
CAUTION
Diprowize OD 750 Tablet PR may cause excessive drowsiness with alcohol.
UNSAFE
Diprowize OD 750 Tablet PR is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
CONSULT YOUR DOCTOR
Diprowize OD 750 Tablet PR should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.
CAUTION

Diprowize 750mg Tablet PR కొరకు సాల్ట్ సమాచారం

Divalproex(750mg)

Diprowize tablet pr ఉపయోగిస్తుంది

{med_name} is used in the treatment of mania, migraine, Bipolar disorder, trigeminal neuralgia, epilepsy/seizures, seizures and epilepsy.

ఎలా diprowize tablet pr పనిచేస్తుంది

Diprowize OD 750 Tablet PR works by calming overactive nerve signals in the brain. It increases certain chemicals that help control brain activity, prevent seizures, stabilize mood in bipolar disorder, and reduce migraine frequency. Balancing brain signals helps manage symptoms effectively and improves overall well-being.

Diprowize tablet pr యొక్క సాధారణ దుష్ప్రభావాలు

Abdominal pain, Accidental injury, Hair loss, Blurred vision, Memory loss, Decreased appetite, Weakness, Abnormality of voluntary movements, Back pain, Bronchitis (inflammation of the airways), Constipation, Depression, Diarrhea, Double vision, Dizziness, Indigestion, Breathlessness, Ecchymosis (discoloration of the skin resulting from bleeding underneath), Emotional lability, Fever, Influenza like syndrome, Headache, Increased appetite, Insomnia (difficulty in sleeping), Nausea, Nervousness, Nystagmus (involuntary eye movement), Peripheral edema, Sore throat, Rash, Inflammation of the nose, Sleepiness, Altered thinking, Low blood platelets, Ringing in ear, Tremors, Vomiting, Weight gain, Weight loss

Diprowize Tablet PR కొరకు ప్రత్యామ్నాయాలు

13 ప్రత్యామ్నాయాలు
అన్నింటిని చూడండి
13 ప్రత్యామ్నాయాలు
అన్నింటిని చూడండి
Sorted By
RelevancePrice
అన్నింటిని చూడండి

సంబంధిత ఉత్పత్తులు

‹›

Diprowize Tablet PR కొరకు నిపుణుల సలహా

  • Take your medication regularly as directed by your doctor, as missing doses can trigger seizures.
  • Take it at the same time every day to maintain consistent levels in your body.
  • It can be taken with or without food; however, consider taking it with food to avoid an upset stomach.
  • Do not change the brand of your medicine, and make sure that you have a sufficient amount of medicine present with you.
  • It may cause dizziness and sleepiness. Do not drive or do anything that requires mental focus until you know how it affects you.
  • Monitor your weight during treatment with this medicine, as it can cause weight gain.
  • Your doctor may get regular blood tests done to monitor how the medication is affecting your body. Inform your doctor if you notice yellowing of the eyes or skin, dark urine, or stomach pain.
  • Avoid consuming alcohol when taking Divalproex, as it may cause excessive sleepiness or drowsiness.
  • Inform your doctor if you develop any unusual changes in mood or behavior, new or worsening depression, or suicidal thoughts or behavior.
  • Do not take Divalproex if you are pregnant or planning to conceive or breastfeed.

Diprowize 750mg Tablet PR గురించి తరచుగా అడిగే ప్రశ్నలు

Divalproex

Q. What happens if I stop taking Diprowize OD 750 Tablet PR?
You should not stop taking Diprowize OD 750 Tablet PR without consulting your doctor. The dose of Diprowize OD 750 Tablet PR should be reduced gradually and eventually can be stopped under the supervision of a doctor or specialist. Suddenly stopping the medication may trigger seizures or lead to the recurrence of symptoms.
Q. Is Diprowize OD 750 Tablet PR a mood stabilizer?
Yes, Diprowize OD 750 Tablet PR can sometimes be used as a mood stabilizer. It is given in patients who experience rapid changes in their mood. It works by calming the hyperactivity of the brain during mood changes.
Q. Can Diprowize OD 750 Tablet PR cause weight gain?
Yes, Diprowize OD 750 Tablet PR may cause weight gain. The gain in weight could be due to an increase in hunger. Keep a check on your diet and exercise regularly to prevent any weight gain. If you are have concerns related to weight gain, consult your doctor.
Show More
Q. Does Diprowize OD 750 Tablet PR make you sleepy?
Yes, Diprowize OD 750 Tablet PR may make you feel sleepy. Avoid driving or other work that requires mental focus until you know how it affects you.
Q. Does Diprowize OD 750 Tablet PR cause hair loss?
Yes, Diprowize OD 750 Tablet PR may cause hair loss. However, it is only for a short time and is usually dose-related. Consult your doctor if the hair loss bothers you or persists for a longer duration.
Q. Can Diprowize OD 750 Tablet PR damage my liver?
Yes, Diprowize OD 750 Tablet PR can cause damage to the liver. The risk is more likely to occur during the first 6 months of starting the treatment with Diprowize OD 750 Tablet PR. Symptoms of liver damage may include nausea or vomiting, loss of appetite, stomach pain, dark-colored urine, facial swelling, yellowing of the skin, or white eyes. Therefore, it is important to have liver function tests done before starting the medicine. Tests should be done periodically during the first 6 months of therapy, especially in those who are likely to be at risk and those with a prior history of liver disease.
Q. Can I take alcohol while I am taking Diprowize OD 750 Tablet PR?
Avoid alcohol consumption while you are on treatment with Diprowize OD 750 Tablet PR. Taking alcohol with this medicine may make you feel more drowsy, light headed or dizzy.
Q. What are the laboratory tests recommended before taking Diprowize OD 750 Tablet PR?
The doctor may suggest blood tests before starting the treatment with Diprowize OD 750 Tablet PR. The tests may include blood cell count, including platelet count, bleeding time, and coagulation tests. These tests are also advised to avoid any spontaneous bruising or bleeding. In addition to this, liver function tests are advised before therapy. It is recommended to periodically monitor liver function during the first 6 months of therapy, primarily in those who seem most at risk and those with a prior history of liver disease.
Q. What should be done if I start experiencing abdominal pain, nausea and anorexia?
If you experience acute, severe abdominal pain along with nausea and vomiting, it may be due to pancreatitis. Immediately consult your doctor in case you experience these symptoms. Your doctor may get your levels of serum amylase checked. In case the test shows positive results for pancreatitis, the medication should be stopped immediately.
Q. How to check for overdose of Diprowize OD 750 Tablet PR?
An overdose of Diprowize OD 750 Tablet PR may cause headaches, blurred eyesight due to the pupils of the eyes becoming smaller, lack of reflexes, confusion, and tiredness. You may also experience weak or “floppy” muscles, fits (seizures), loss of consciousness, behavioral changes, and breathing difficulties such as fast breathing, shortness of breath, or chest pain. Immediate medical assistance is required in case of overdose.

Content on this page was last updated on 17 July, 2025, by Dr. Mekhala Chandra (MD, MBBS)